Affinivax is a clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases.
This novel and highly efficient vaccine technology – called Multiple Antigen Presenting System (MAPS) – enables the high affinity binding of protective polysaccharides as well as proteins in a single vaccine, uniquely induci...
Affinivax is a clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases.
This novel and highly efficient vaccine technology – called Multiple Antigen Presenting System (MAPS) – enables the high affinity binding of protective polysaccharides as well as proteins in a single vaccine, uniquely inducing a broad and protective B- and T-cell immune response.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.